The presence of FLT3-ITD mutations, particularly those with a high allelic ratio, is a strong adverse prognostic factor for overall survival in AML patients receiving allogeneic stem cell transplantation (20, 21). The gene discussed is FLT3; the disease is acute myeloid leukemia.